Volume | 256,347 |
|
|||||
News | - | ||||||
Day High | 19.7382 | Low High |
|||||
Day Low | 19.2058 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
19.72 | 19.2058 | 19.7382 | 19.88 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
3,411 | 256,347 | US$ 19.39 | US$ 4,971,617 | - | 12.3202 - 32.10 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
12:33:00 | 36 | US$ 19.29 | USD |
Cassava Sciences (SAVA) Options Flow Summary
Cassava Sciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.3M | 43.23M | - | 0 | -97.22M | -2.25 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cassava Sciences News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 19.00 | 20.92 | 18.6709 | 19.41 | 581,622 | 0.28 | 1.47% |
1 Month | 22.35 | 22.8999 | 18.6709 | 20.57 | 575,516 | -3.07 | -13.74% |
3 Months | 19.89 | 26.6757 | 18.6709 | 21.71 | 815,103 | -0.61 | -3.07% |
6 Months | 29.48 | 30.13 | 18.18 | 22.81 | 811,677 | -10.20 | -34.60% |
1 Year | 24.45 | 32.10 | 12.3202 | 21.40 | 982,815 | -5.17 | -21.15% |
3 Years | 78.00 | 146.16 | 12.3202 | 48.82 | 2,319,510 | -58.72 | -75.28% |
5 Years | 1.18 | 146.16 | 1.03 | 34.14 | 2,801,745 | 18.10 | 1,533.90% |
Cassava Sciences Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. |